Related Experiment Video

Updated: Jun 20, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Potential targets and their relevant inhibitors in anti-influenza fields

Jianzhi Gong1, Hao Fang, Minyong Li

  • 1Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China. drgongjianzhi@yahoo.com.cn

Current Medicinal Chemistry
|September 15, 2009
PubMed

Insights

This review explores antiviral strategies against influenza, focusing on novel targets within viral factors like hemagglutinin (HA) and host factors such as v-ATPase. It discusses inhibitors for these key targets to combat influenza infections.

Area of Science:

  • Virology and Molecular Biology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Influenza affects millions annually, with significant concern over highly pathogenic H5N1 avian influenza and its pandemic potential.
  • Advancements in viral biology have spurred the development of novel antiviral strategies.
  • Understanding viral and host factors is crucial for effective influenza treatment.

Purpose of the Study:

  • To review established and potential anti-influenza therapeutic targets.
  • To discuss inhibitors targeting both viral and host factors involved in influenza replication.
  • To provide an overview of current and emerging antiviral strategies against influenza viruses.

Main Methods:

  • Literature review of scientific publications on influenza virology and antiviral drug development.
  • Analysis of viral factors including hemagglutinin (HA), M2 ion channel protein, RNA-dependent RNA polymerase (RdRp), nucleoprotein (NP), non-structural protein (NS), and neuraminidase (NA).
  • Examination of host factors such as v-ATPase, protease, inosine monophosphate dehydrogenase (IMPDH), and intracellular signaling cascades.

Main Results:

  • Identified multiple viral proteins (HA, M2, RdRp, NP, NS, NA) as key targets for antiviral intervention.
  • Highlighted host cellular machinery (v-ATPase, proteases, IMPDH, signaling pathways) as potential targets to disrupt viral replication.
  • Summarized various inhibitors developed against these viral and host targets.

Conclusions:

  • A diverse range of viral and host targets offer promising avenues for novel anti-influenza therapies.
  • Targeting host factors presents a strategy to overcome viral resistance.
  • Continued research into these targets and their inhibitors is essential for pandemic preparedness.

More Related Videos

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...